The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
Open accessAbstract
Epithelial–mesenchymal transition (EMT) and the reverse process, mesenchymal–epithelial transition (MET), are essential during development and in the regulation of stem cell pluripotency, yet these processes are also activated in pathological contexts, such as in fibrosis and cancer progression. In EMT and MET, diverse signaling pathways cooperate in the initiation and progression of the EMT and MET programs, through regulation at transcriptional, post-transcriptional, translational, and post-translational levels. MicroRNAs recently emerged as potent regulators of EMT and MET, with their abilities to target multiple components involved in epithelial integrity or mesenchymal traits. By affecting EMT and MET processes, microRNAs are involved in the regulation of stem cell pluripotency and the control of tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Vetter, G., Saumet, A., Moes, M., Vallar, L., Béchec, A. L., Laurini, C., Sabbah, M., Arar, K., Theillet, C. G., Lecellier, C., et al. (2010) · Oncogene · doi:10.1038/onc.2010.181 · Cited by 125
RetractedValastyan, S., Chang, A., Benaich, N., Reinhardt, F., & Weinberg, R. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0410 · Cited by 107
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“These transcription factors act to repress E-cadherin expression, a major component of adherens junctions and hallmark of the epithelial integrity [5].”
BackgroundTGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Self-citationEpithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., & Wrana, J. L. (2005) · Science · doi:10.1126/science.1105718 · Cited by 881
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Kong, W., Yang, H., He, L., Zhao, J.-J., Coppola, D., Dalton, W. S., & Cheng, J. Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-08 · Cited by 689
Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
Yang, M.-H., Hsu, D. S.-S., Wang, H.-W., Wang, H.-J., Lan, H.-Y., Yang, W.-H., Huang, C.-H., Kao, S.-Y., Tzeng, C.-H., Tai, S.-K., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2099 · Cited by 631
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 598
Self-citationp53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 514
Mechanisms of Motility in Metastasizing Cells
Yilmaz, M., & Christofori, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0139 · Cited by 477
Zheng, F., Liao, Y.-J., Cai, M.-Y., Liu, Y.-H., Liu, T.-H., Chen, S.-P., Bian, X.-W., Guan, X.-Y., Lin, M. C., Zeng, Y.-X., et al. (2012) · Gut · doi:10.1136/gut.2011.239145 · Cited by 376
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer
Stinson, S., Lackner, M. R., Adai, A. T., Yu, N., Kim, H.-J., O’Brien, C., Spoerke, J., Jhunjhunwala, S., Boyd, Z., Januario, T., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001538 · Cited by 303
Small RNA-mediated regulation of iPS cell generation: RNA-based iPSC reprogramming
Li, Z., Yang, C.-S., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 302
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
Liu, Y.-N., Yin, J. J., Abou-Kheir, W., Hynes, P. G., Casey, O. M., Fang, L., Yi, M., Stephens, R. M., Seng, V, Sheppard-Tillman, H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.58 · Cited by 295
Smith, A. L., Iwanaga, R., Drasin, D. J., Micalizzi, D. S., Vartuli, R. L., Tan, A.-C., & Ford, H. L. (2012) · Oncogene · doi:10.1038/onc.2012.11 · Cited by 293
Progress in understanding reprogramming to the induced pluripotent state
Plath, K., & Lowry, W. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2955 · Cited by 289
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Keklikoglou, I., Koerner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T., Schneeweiss, A., et al. (2012) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273
Liao, B., Bao, X., Liu, L., Feng, S., Zovoilis, A., Liu, W., Xue, Y., Cai, J., Guo, X., Qin, B., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.235960 · Cited by 264
TGF-β-induced epithelial to mesenchymal transition
Jian, J. I. A. N., Xü, Samy, Lamouille, Rik, & Derynck (2009) · Cell Research · Cited by 252
Sun, L., Yao, Y., Liu, B., Lin, Z., Lin, L., Yang, M., Zhang, W., Chen, W., Pan, C., Liu, Q., et al. (2012) · Oncogene · doi:10.1038/onc.2011.263 · Cited by 249
Han, M., Liu, M., Wang, Y., Chen, X., Xu, J., Sun, Y., Zhao, L., Qu, H., Fan, Y., & Wu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039520 · Cited by 247
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
Scheel, C., & Weinberg, R. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26311 · Cited by 233
MicroRNA‐204/211 alters epithelial physiology
Wang, F. E., Zhang, C., Maminishkis, A., Dong, L., Zhi, C., Li, R., Zhao, J., Majerciak, V., Gaur, A. B., Chen, S., et al. (2010) · The FASEB Journal · doi:10.1096/fj.08-125856 · Cited by 230
Zhao, X., Dou, W., He, L., Liang, S., Tie, J., Liu, C., Li, T., Lu, Y., Mo, P., Shi, Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.156 · Cited by 218
Meng, Z., Fu, X., Chen, X., Zeng, S., Tian, Y., Jove, R., Xu, R., & Huang, W. (2010) · Hepatology · doi:10.1002/hep.23915 · Cited by 204
Watanabe, S., Ueda, Y., Akaboshi, S.-I., Hino, Y., Sekita, Y., & Nakao, M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080523 · Cited by 201
Ru, P., Steele, R., Newhall, P., Phillips, N. J., Toth, K., & Ray, R. B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0100 · Cited by 200
MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell lines
Liu, X., Wang, C., Chen, Z., Jin, Y., Wang, Y., Kolokythas, A., Dai, Y., & Zhou, X. (2011) · Biochemical Journal · doi:10.1042/bj20111006 · Cited by 181
Jiang, L., Liu, X., Kolokythas, A., Yu, J., Wang, A., Heidbreder, C. E., Shi, F., & Zhou, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25320 · Cited by 175
Moes, M., Le Béchec, A., Crespo, I., Laurini, C., Halavatyi, A., Vetter, G., del Sol, A., & Friederich, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035440 · Cited by 172
Zhang, J., Zhang, H., Liu, J., Tu, X., Zang, Y., Zhu, J., Chen, J., Dong, L., & Zhang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.121 · Cited by 160
Papadimitriou, E., Vasilaki, E., Vorvis, C., Iliopoulos, D., Moustakas, A., Kardassis, D., & Stournaras, C. (2011) · Oncogene · doi:10.1038/onc.2011.457 · Cited by 123
Ming-li, H., Liu, M., Wang, Y., Mo, Z., Bi, X., Liu, Z., Fan, Y., Chen, X., & Wu, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1195-5 · Cited by 115
MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1
Qi, J., Rice, S. J., Salzberg, A. C., Runkle, E. A., Liao, J., Zander, D. S., & Mu, D. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18576 · Cited by 81
Xia, H., & Hui, K. M. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.58 · Cited by 81
From microRNAs to targets: pathway discovery in cell fate transitions
Subramanyam, D., & Blelloch, R. H. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.04.011 · Cited by 70
Self-citationInverse Association between miR-194 Expression and Tumor Invasion in Gastric Cancer
Song, Y., Zhao, F., Wang, Z., Liu, Z., Chiang, Y.-P., Xu, Y., Gao, P., & Xu, H. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1999-2 · Cited by 58
Zhou, Q., Fan, J., Ding, X., Peng, W., Yu, X., Chen, Y., & Nie, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141341 · Cited by 55
Cited by
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Self-citationNieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Hao, Y., Baker, D., & ten Dijke, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112767 · Cited by 1,142
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Metadata
- Authors
- Lamouille, S., Subramanyam, D., Blelloch, R., & Derynck, R.
- Venue
- Current Opinion in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 25
- Issue
- 2
- Pages
- 200-207
- ISSN
- 0955-0674 (ISSN-L)
- OpenAlex
- W2039214381
- Cited by
- 259
- References
- 53
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.